Amrita Krishnan, M.D. Director of the Judy and Bernard Briskin Center for Multiple Myeloma Research Director, Multiple Myeloma Program Associate Director, Medical Education & Training Program Professor, Department of Hematology & Hematopoietic Cell Transplantation, City Of Hope, Discusses Myeloma In 2019 Including The SWOG s1803 Trial And Data. Dr. Krishnan Discusses Where The Myeloma Field Is Going For Example Higher Efficacy, Minimize long term toxicities, & MRD-Driven Therapy. She Discusses If You Should Use The Best Available Therapies Upfront Or Save The Best For Later And Even Dives Into The Maia Trial Design. This Was All discussed At MOASC Oncology Summit On Feb 23, 2019.
For More Info Visit: https://moasc.org…
Advertisement